NanoViricides
NNVC
#10561
Rank
S$43.42 M
Marketcap
S$1.70
Share price
0.76%
Change (1 day)
-22.30%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : S$1.52 Million

According to NanoViricides's latest financial reports the company's total liabilities are S$1.52 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30S$2.75 M379.27%
2022-06-30S$0.57 M21.54%
2021-06-30S$0.47 M-84.29%
2020-06-30S$3 M-21.94%
2019-06-30S$3.85 M220.31%
2018-06-30S$1.2 M-86.93%
2017-06-30S$9.19 M-49.75%
2016-06-30S$18.3 M9.53%
2015-06-30S$16.7 M-34.59%
2014-06-30S$25.54 M139.71%
2013-06-30S$10.65 M372.61%
2012-06-30S$2.25 M212.93%
2011-06-30S$0.72 M-79.02%
2010-06-30S$3.43 M361.09%
2009-06-30S$0.74 M-46.57%
2008-06-30S$1.39 M6.95%
2007-06-30S$1.3 M-45.07%
2006-06-30S$2.37 M2023.58%
2005-06-30S$0.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
S$48.09 B 3,159,164.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$112.27 B 7,375,101.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$83.56 B 5,489,687.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$90.44 B 5,941,523.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S$1.46 B 96,167.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.29 B 84,902.35%๐Ÿ‡บ๐Ÿ‡ธ USA